Basilea Pharmaceutica’s CHF 75 Million Senior Secured Loan Agreement with Athyrium

Federica Tiefenthaler
Tagged:

BianchiSchwald advised Athyrium on the deal.The listed company Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company entered into a senior secured loan agreement with funds…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now